Medicon A/S opens its second office in Sweden
"This important step will strengthen our cooperation with our Swedish investigators and clients. We will get in closer contact with the people we work with. It is a positive consequence of the increasing demand from our clients, and will also support our strategy for expansion in early phase trials. We will be in a better position to guarantee our clients optimal and prompt services and better patient access," says Dr. Haahr, CEO of Medicon A/S.
Helena Lüning has been appointed Country Manager for Sweden. She brings more than 15 years of experience from clinical research and marketing. With her insight and commitment to clinical studies, Helena Lüning will be working out of the new Stockholm office.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.